If you need more lookups,
subscriptions start at $34 USD/month.
Isabel Cano Sanchez Location
Madrid, ES
Isabel Cano Sanchez Work
Global Medical Communications Lead Neurology and Rare @ (June 2023 - Present)
Medical Activities Coordinator UCB Iberia @ (February 2013 - April 2015)
Medical Sciences Liaison UCB Iberia @ (November 2007 - February 2013)
Clinical Research Associate @ (March 2006 - November 2007)
Clinical Research Associate @ (October 2003 - March 2006)
EU Rare Diseases Medical Content Communication and Omnichannel and Customer Experience Lead at UCB @ (July 2022 - June 2023)
EU CNS Medical Customer Experience Lead at UCB @ (June 2017 - February 2023)
Senior Medical Manager Iberia @ (January 2017 - June 2017)
Epilepsy Medical Manager Iberia @ (May 2015 - December 2016)
Isabel Cano Sanchez Education
Universidad Alcala de Henares
Isabel Cano Sanchez Skills
Clinical Trials
Medical Education
Neurology
Neuroscience
Biotechnology
Life Sciences
Molecular Biology
Medical Writing
Epilepsy
Lifesciences
Clinical Research
Pharmaceutical Industry
Movement Disorders
sleep (narcolepsy)
hyperkinetic movement disorders (Huntington disease
Clinical Operations
Medical Affairs
Pharmacovigilance
Sales staff medical training
Scientific Review
Protocol Design
EU/ Spanish clinical trials legislation
Clinical Development
GCP
CTMS
ICH-GCP
Clinical Monitoring
Product Launch
CRO
Sleep Narcolepsy
Ich Gcp
Hyperkinetic Movement Disorders Huntington Disease
Sleep
Hyperkinetic Movement Disorders
Isabel Cano Sanchez Summary
Isabel Cano Sanchez, based in Madrid, ES, is currently a Global Medical Communications Lead Neurology and Rare at UCB. Isabel Cano Sanchez brings experience from previous roles at UCB, UCB Pharma and Roche Pharmaceuticals. Isabel Cano Sanchez holds a Universidad Alcala de Henares. With a robust skill set that includes Clinical Trials, Medical Education, Neurology, Neuroscience, Biotechnology and more. Isabel Cano Sanchez has 3 emails on RocketReach.
Looking for a different Isabel Cano Sanchez?
Find contact details for 700 million professionals.